Actions and therapeutic pathways of ghrelin for gastrointestinal disorders

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 6, 2009, Pages 343-352

  Camilleri, Michael ^a   Papathanasopoulos, Athanasios ^a   Odunsi, Suwebatu T ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; EXENDIN 4; GHRELIN; GHRELIN AGONIST; GHRELIN RECEPTOR; GLUCAGON LIKE PEPTIDE 1; HORMONE ANTAGONIST; IBUTAMOREN; LIRAGLUTIDE; MOTILIN; PEPTIDE YY; PLACEBO; PROKINETIC AGENT; RIMONABANT; SEROTONIN AGONIST; SMALL MOLECULE GHRELIN RECEPTOR ANTAGONIST; TZP 101; TZP 102; UNCLASSIFIED DRUG; YIL 870;

BARIATRIC SURGERY; BLOOD BRAIN BARRIER; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENERGY METABOLISM; FOOD INTAKE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYPERGLYCEMIA; ILEUS; INCREASED APPETITE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; INTESTINE CONTRACTION; LOW DRUG DOSE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; WEIGHT REDUCTION;

ENERGY METABOLISM; GASTRIC EMPTYING; GASTROINTESTINAL DISEASES; GHRELIN; HUMANS;

EID: 67149136168     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.72     Document Type: Review

References (90)

1. Asakawa, A. et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120, 337-345 (2001).
2. Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660 (1999).
3. Howard, A. D. et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974-977 (1996).
4. Bowers, C. Y. et al. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 106, 663-667 (1980).
5. Wren, A. M. et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328 (2000).
6. Kim, S. W. et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-e1 cells. Bone 37, 359-369 (2005).
7. Nagaya, N. et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1483-R1487 (2001).
8. Eisenstein, J. & Greenberg, A. Ghrelin: Update. Nutr. Rev. 61 101-104 (2003).
9. Nass, R. et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: A randomized trial. Ann. Intern. Med. 149, 601-611 (2008).
10. Date, Y. et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 4255-4261 (2000).
11. Lu, S. et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci. Lett. 321, 157-160 (2002).
12. Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNs demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003).
13. Papotti, M. et al. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85, 3803-3807 (2000).
14. Banks, W. A., Tschop, M., robinson, S. M. & Heiman, M. L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302, 822-827 (2002).
15. Date, Y. et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120-1128 (2002).
16. Takeno, R. et al. Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur. J. Endocrinol. 151, 447-450 (2004).
17. Kanamoto, N. et al. Genomic structure and characterization of the 5′-flanking region of the human ghrelin gene. Endocrinology 145, 4144-4153 (2004).
18. Gardiner, J. & Bloom, S. Ghrelin gets its GOAT. Cell. Metab. 7 193-194 (2008).
19. Pemberton, C., Wimalasena, P., Yandle, T., Soule, S. & Richards, M. C-terminal pro-ghrelin peptides are present in the human circulation. Biochem. Biophys. Res. Commun. 310, 567-573 (2003).
20. Zhang, J. V. et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996-999 (2005).
21. Gourcerol, G. & Tache, Y. Obestatin - a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol. Motil. 19, 161-165 (2007).
22. Bang, A. S., Soule, S. G., Yandle, T. G., Richards, A. M. & Pemberton, C. J. Characterisation of proghrelin peptides in mammalian tissue and plasma. J. Endocrinol. 192, 313-323 (2007).
23. Hosoda, H., Kojima, M., Mizushima, T., Shimizu, S. & Kangawa, K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by posttranslational processing. J. Biol. Chem. 278, 64-70 (2003).
24. Toshinai, K. et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147, 2306-2314 (2006).
25. Qader, S. S., Hakanson, R., Rehfeld, J. F., Lundquist, I. & Salehi, A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: A study on isolated islets from mouse and rat pancreas. Regul. Pept. 146, 230-237 (2008).
26. Thompson, N. M. et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 234-242 (2004).
27. Asakawa, A. et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54, 18-24 (2005).
28. Granata, R. et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: Involvement of 3′, 5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148, 512-529 (2007).
29. Yang, J., Brown, M. S., Liang, G., Grishin, N. V. & Goldstein, J. L. identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396 (2008).
30. Gualillo, O., Lago, F. & Dieguez, C. Introducing GOAT: A target for obesity and anti-diabetic drugs? Trends Pharmacol. Sci. 29, 398-401 (2008).
31. Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908-913 (2000).
32. Sanchez, J., Oliver, P., Palou, A. & Pico, C. The inhibition of gastric ghrelin production by food intake in rats is dependent on the type of macronutrient. Endocrinology 145, 5049-5055 (2004).
33. de la Cour, C. D., Norlen, P. & Hakanson, R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: A microdialysis study. Regul. Pept. 143, 118-126 (2007).
34. Bellone, s. et al. Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding. J. Clin. Endocrinol. Metab. 89, 1662-1665 (2004).
35. Shiiya, T. et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87, 240-244 (2002).
36. Pekic, s. et al. Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administration. Clin. Endocrinol. (Oxf.) 64, 684-688 (2006).
37. Kim, M. S. et al. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 14, 1317-1320 (2003).
38. Wren, A. M. et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540-2547 (2001).
39. Inui, A. Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nat. Rev. Neurosci. 2, 551-560 (2001).
40. Wren, A. M. et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992-5995 (2001).
41. Smith, R. G. et al. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18, 621-645 (1997).
42. Horvath, T. L., Diano, S., Sotonyi, P., Heiman, M. & Tschop, M. Minireview: Ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology 142, 4163-4169 (2001).
43. Gil-Campos, M., Canete, r. & Gil, A. Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int. J. Obes. Relat. Metab. Disord. 28 (suppl. 3), S75-S80 (2004).
44. Haqq, A. M. et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88, 174-178 (2003).
45. Asakawa, A. et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52, 947-952 (2003).
46. strassburg, S. et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. 295, E78-E84 (2008).
47. Gil-Campos, M., Aguilera, C. M., Canete, R. & Gil, A. Ghrelin: A hormone regulating food intake and energy homeostasis. Br. J. Nutr. 96 201-226 (2006).
48. Olszewski, P. K., Schioth, H. B. & Levine, A. S. Ghrelin in the CNS: from hunger to a rewarding and memorable meal? Brain Res. Rev. 58, 160-170 (2008).
49. Venkova, K. & Greenwood-van Meerveld, B. Application of ghrelin to gastrointestinal diseases. Curr. Opin. Investig. Drugs 9, 1103-1107 (2008).
50. Peeters, T. L. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. Curr. Opin. Pharmacol. 6 553-558 (2006).
51. Lasseter, K. C. et al. Ghrelin agonist (TZP-101): Safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study. J. Clin. Pharmacol. 48, 193-202 (2008).
52. Fraser, G. L., Hoveyda, H. R. & Tannenbaum, G. S. Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist. Endocrinology 149, 6280-6288 (2008).
53. Tranzymer® Pharma [online] http://www.tranzyme.com (2009).
54. Delhanty, P. J. et al. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am. J. Physiol. Endocrinol. Metab. 293, E302-E309 (2007).
55. Frasca, F. et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch. Physiol. Biochem. 114, 23-37 (2008).
56. Koo, G. C. et al. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 166, 4195-4201 (2001).
57. Katergari, s. A., Milousis, A., Pagonopoulou, O., Asimakopoulos, B. & Nikolettos, N. K. Ghrelin in pathological conditions. Endocr. J. 55, 439-453 (2008).
58. Cremonini, F. et al. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology 131, 1431-1439 (2006).
59. Sanger, G. J. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov. Today 13, 234-239 (2008).
60. Tack, J. et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55, 327-333 (2006).
61. Peeters, T. L. Central and peripheral mechanisms by which ghrelin regulates gut motility. J. Physiol. Pharmacol. 54, 95-103 (2003).
62. Qiu, W. C., Wang, Z. G., Wang, W. G., Yan, J. & Zheng, Q. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis. World J. Gastroenterol. 14, 1419-1424 (2008).
63. Murray, C. D. et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: A double blind, placebo controlled, crossover study. Gut 54, 1693-1698 (2005).
64. Tack, J. et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther. 22, 847-853 (2005).
65. Binn, M. et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 27, 1603-1606 (2006).
66. Levin, F. et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J. Clin. Endocrinol. Metab. 91, 3296-3302 (2006).
67. Esler, W. P. et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148, 5175-5185 (2007).
68. Adeghate, E. & Ponery, A. S Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J. Neuroendocrinol. 14, 555-560 (2002).
69. Volante, M. et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 87, 1300-1308 (2002).
70. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53, 3142-3151 (2004).
71. Sun, Y., Wang, P., Zheng, H. & Smith, R. G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl Acad. Sci. USA 101 4679-4684 (2004).
72. Damjanovic, S. S. et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. J. Clin. Endocrinol. Metab. 91, 2574-2581 (2006).
73. Chapman, I. M. et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J. Clin. Endocrinol. Metab. 81, 4249-4257 (1996).
74. Sun, Y., Asnicar, M., Saha, P. K., Chan, L. & Smith, R. G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell. Metab. 3, 379-386 (2006).
75. Takahashi, H. et al. Ghrelin differentially modulates glucose-induced insulin secretion according to feeding status in sheep. J. Endocrinol. 194, 621-625 (2007).
76. Dezaki, K. et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55, 3486-3493 (2006).
77. Broglio, F. et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J. Clin. Endocrinol. Metab. 89, 3062-3065 (2004).
78. Gauna, C. et al. Ghrelin stimulates, whereas desoctanoyl ghrelin inhibits, glucose output by primary hepatocytes. J. Clin. Endocrinol. Metab. 90, 1055-1060 (2005).
79. Zhang, Y. et al. Ghrelin inhibits cell apoptosis in pancreatic beta cell line HIT-T15 via mitogen-activated protein kinase/ phosphoinositide 3-kinase pathways. Toxicology 237, 194-202 (2007).
80. Sun, Y., Ahmed, S. & Smith, R. G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23, 7973-7981 (2003).
81. Sun, Y., Butte, N. F., Garcia, J. M. & Smith, R. G. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149, 843-850 (2008).
82. Deitel, M., Crosby, R. D. & Gagner, M. The First International Consensus summit for sleeve Gastrectomy (SG), New York City, October 25-27, 2007. Obes. Surg. 18, 487-496 (2008).
83. Schauer, P. R. & Schirmer, B. D. in Schwartz's Principles of Surgery 8th edn (ed. Brunicardi, F.) (McGraw-Hill Health Professions Division, New York, 2005).
84. O'Brien, P. e. et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann. Intern. Med. 144, 625-633 (2006).
85. Sjostrom, L. et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 351 2683-2693 (2004).
86. Sjostrom, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741-752 (2007).
87. Cummings, D. e. et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630 (2002).
88. Shak, J. et al. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes. Surg. 18, 1089-1096 (2008).
89. le Roux, C. W. et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann. Surg. 246, 780-785 (2007).
90. Kojima, M., Hosoda, H., Matsuo, H. & Kangawa, K. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12, 118-122 (2001).